Afuresertib (GSK2110183)
日期:2018-09-05 17:14 人气:
Catalog_no | ADMC0929 |
Product_name | Afuresertib (GSK2110183) |
Category | 抑制剂与激动剂 |
Size | 10mg/50mg/100mg |
Price | 1660.00/5000.00/7220.00 |
Specificity | Target: Akt . Fields: Afuresertib (GSK2110183) is a potent, orally bioavailable Akt inhibitor with Ki of 0.08 nM, 2 nM, and 2.6 nM for Akt1, Akt2, and Akt3, respectively. Phase 2. Ki: 0.08 nM (AKT1), 2 nM (AKT2), 2.6 nM (AKT3)[1] IC50: 0.2 nM (AKT1E |
Dilution | Ki: 0.08 nM (AKT1), 2 nM (AKT2), 2.6 nM (AKT3)[1] IC50: 0.2 nM (AKT1E17K), 1.3 nM (PKA), 0.9 nM (PKG1α), 4 nM (PKG1β)[1] |
Purification | >98% |
Concentration | 靶点:Akt;IC50:Ki: 0.08 nM (AKT1), 2 nM (AKT2), 2.6 nM (AKT3)[1] 0.2 nM (AKT1E17K), 1.3 nM (PKA), 0.9 nM (PKG1α), 4 nM (PKG1β)[1] |
Storage_stability | 2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO |
Molecular Weight | 427.32 |
Notes | Afuresertib (GSK2110183) is a potent, orally bioavailable Akt inhibitor with Ki of 0.08 nM, 2 nM, and 2.6 nM for Akt1, Akt2, and Akt3, respectively. Phase 2. Ki: 0.08 nM (AKT1), 2 nM (AKT2), 2.6 nM (AKT3)[1] IC50: 0.2 nM (AKT1E17K), 1.3 nM (PKA), 0. |
Instructions | 查看与下载 |
- 产品详情
- 发表文献
- 用户反馈
- 相关产品
- 在线问答